Download Files:
Products Details
Product Description
– FGFR4-IN-4 (compound 693) is a FGFR4 inhibitor with anti-tumor activity, extracted from patent WO2018113584A1[1].
Web ID
– HY-129181
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C28H32Cl2N6O5
References
– [1]YANG, Fei, et al. FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF. WO2018113584A1.
CAS Number
– 2230973-67-6
Molecular Weight
– 603.50
SMILES
– C=CC(N[C@H]1COC[C@H]1NC2=NC=C3C(C(N4CCC(OC)CC4)=NC(C5=C(Cl)C(OC)=CC(OC)=C5Cl)=C3)=N2)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– FGFR
Isoform
– FGFR4
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
